Saba Capital Management, L.P. has made a notable transaction by acquiring 300 shares of Gabelli Healthcare & WellnessRx Trust. This transaction, filed on October 28, 2026, is significant as it reflects Saba's continued investment strategy in the healthcare sector.

According to the SEC filing, the transaction took place on October 27, 2026, with the shares purchased at a price of $9.99 each. Following this acquisition, Saba Capital now holds a total of 2,174,125 shares in Gabelli Healthcare & WellnessRx Trust.

Background

Saba Capital Management, L.P., incorporated in Delaware, is an investment management firm. The company is known for its strategic investments across various sectors, including healthcare. Their recent filings indicate a proactive approach to managing their portfolio, with several transactions reported on the same day.

What the Filing Says

The SEC filing details that Saba Capital Management acquired 300 shares of Gabelli Healthcare & WellnessRx Trust on October 27, 2026, at a price of $9.99 per share. The document emphasizes that the securities are held by funds and accounts managed by Saba, with Boaz R. Weinstein serving as the managing member of the general partner.

Impact

This acquisition may have implications for both Saba Capital and Gabelli Healthcare & WellnessRx Trust. As a ten percent owner, Saba's investment decisions could influence the management and strategic direction of Gabelli Trust. Other investment firms in the healthcare sector will likely monitor Saba's moves closely to assess market trends and potential shifts in investor sentiment.

What's Next

The filing does not say what happens next.